The first human who received an implant from Neuralink underwent the procedure at Barrow Neurological Institute, according to an April 12 news release from Barrow. The implant is about the size of a quarter and is placed in a person’s skull by a surgical robot.
The Neuralink PRIME Study is looking for adults with quadriplegia due to vertical spinal cord injury or ALS. These adults, according to the release, need to be at least 22 years old and have someone to help them take part in the study.
Neuralink was founded in 2017 and received FDA clearance for clinical trials in humans in May.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
